Barclays’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91K Sell
31,580
-478,309
-94% -$1.88M ﹤0.01% 4066
2025
Q4
$2.08M Sell
509,889
-15,967
-3% -$71.5K ﹤0.01% 2910
2025
Q3
$1.87M Buy
525,856
+31,441
+6% +$114K ﹤0.01% 2939
2025
Q2
$1.35M Sell
494,415
-7,028
-1% -$14.5K ﹤0.01% 3130
2025
Q1
$842K Buy
501,443
+182,960
+57% +$511K ﹤0.01% 3207
2024
Q4
$519K Sell
318,483
-427
-0.1% -$1.27K ﹤0.01% 3798
2024
Q3
$1.33M Buy
318,910
+178,179
+127% +$936K ﹤0.01% 3162
2024
Q2
$768K Buy
140,731
+24,720
+21% +$197K ﹤0.01% 2759
2024
Q1
$1.16M Sell
116,011
-234,603
-67% -$1.76M ﹤0.01% 2999
2023
Q4
$1.43M Buy
350,614
+145,047
+71% +$534K ﹤0.01% 3177
2023
Q3
$796K Buy
205,567
+6,096
+3% +$32.8K ﹤0.01% 2495
2023
Q2
$1.19M Sell
199,471
-17,377
-8% -$100K ﹤0.01% 2196
2023
Q1
$709K Sell
216,848
-86,262
-28% -$345K ﹤0.01% 2996
2022
Q4
$1.2M Buy
303,110
+9,883
+3% +$48.3K ﹤0.01% 2661
2022
Q3
$1.76M Buy
293,227
+264,030
+904% +$1.91M ﹤0.01% 1839
2022
Q2
$188K Sell
29,197
-20,753
-42% -$132K ﹤0.01% 3465
2022
Q1
$412K Buy
+49,950
New +$404K ﹤0.01% 3023

Other funds holding SANA